PV701
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PV701, covering 2011-04-26 to 2013-01-24. Get the full timeline:
Most recent: Clinical Trial Update: Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck [Phase 1]